Our senior staff are recognized leaders in the field of risk assessment and have been involved in the development and management of risks on both a national and international level. 

Drs Farber and Page have played major roles in the development of FDA, EPA and OECD and GLP guidelines during their extensive government service.

Dr. Farber significantly contributed to the development of FDA's Red Book toxicology guidelines for food additive , FDA's Sensitivity of Method procedures, OCED toxicology guidelines, GLP guidelines, and EPA's cancer guidelines and maximum tolerated dose principles.

Dr. Page has significantly contributed to the development of the chronic bioassay program at the National Cancer Institute, the development of the EPA's Toxic Substances Control Act and the OECD toxicology guidelines.  

Our experts assist clients in evaluating the potential health risks poised by consumer products, foods, food and feed additives, pharmaceuticals, nutraceuticals, pesticides, and industrial chemicals. 

Our firm offers our clients a unique technical strength, along with an unmatched depth of experience in applying these skills to real- world problems.

ToxaChemica makes a practice to gain a full understanding of a client's problem, including the specific regulatory or legal context in which it has arisen, and to ensure that the risk assessment achieves a realistic definition of the health and environmental risks posed. 

Risk assessment reports prepared by your firm can be used in support of corporate risk management and communication strategies.